PRINCETON, NJ -- (MARKET WIRE) -- January 03, 2007 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer, and Al Altomari, Chief Operating Officer, are scheduled to provide a company update at the 25th Annual JPMorgan Healthcare Conference.
